Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

The Breast(2025)10.1016/j.breast.2025.104547Source: DataRank Database

Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial is a research paper published in The Breast (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times, with 2 citing works in its 1-hop citation network.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access2 citations · 2 citing works in its network

Download PDF

Cite:

Linked data & code

nct doi

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02308085

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 4.00)OA: goldTopics (102)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

From 0 citing papers with measurable signal

This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.

Learn more about DataRank methodology →

Authors (36)

Samuel M. Niman,Ann H. Partridge ORCID,Daniela Diego ORCID,Roswitha Kammler ORCID,Monica Ruggeri ORCID

Live enrichment

PubMed:40743662 PMC:PMC12336806 OpenAlex:https://openalex.org/W4412658536

NCI NIH HHS

Grant: U10 CA180888

NCI NIH HHS

Grant: U24 CA196171

NCI NIH HHS

Grant: UG1 CA189823

NCI NIH HHS

Grant: U10 CA180863

NCI NIH HHS

Grant: U10 CA180868

NCI NIH HHS

Grant: UG1 CA189828

NCI NIH HHS

Grant: UG1 CA189974

National Institutes of Health

Grant: 5U10CA180863-08

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network

National Institutes of Health

Grant: 3U24CA196171-04S1

THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE

National Institutes of Health

Grant: 5U10CA180868-09

NRG Oncology Network Group Operations Center

National Institutes of Health

Grant: 5UG1CA189974-10

SWOG NCORP Research Base

National Institutes of Health

Grant: 5UG1CA189828-10

ECOG-ACRIN NCORP Research Base

National Institutes of Health

Grant: 3U10CA180888-03S1

SWOG Network Group Operations Center of the NCTN

National Institutes of Health

Grant: 3UG1CA189867-03S1

NRG Oncology NCORP Research Base

National Institutes of Health

Grant: 5UG1CA189823-04

Alliance NCORP Research Base

Fond National de la Recherche Scientific

FWCI

4.00

Citation Percentile

0.9%

Citation Trend

2026

goldLicense: CC BY NC ND

journalhttps://www.thebreastonline.com/article/S0960-9776(25)00564-8/pdf

publisherhttps://www.thebreastonline.com/article/S0960-9776(25)00564-8/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0960977625005648?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0960977625005648?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.breast.2025.104547

Fields of Study

Reproductive Biology and FertilityCancer Risks and FactorsOvarian function and disorders04 agricultural and veterinary sciences0402 animal and dairy scienceAdultFemaleHumansPregnancyAnti-Mullerian HormoneAntineoplastic Agents, HormonalBreast NeoplasmsChemotherapy, AdjuvantFertilityFertility PreservationFollicle Stimulating HormoneOvarian ReservePremenopausePrimary Ovarian InsufficiencyProgesteroneProlactinThyrotropin

MeSH Terms

AdultBreast NeoplasmsFemaleFertilityFollicle Stimulating HormoneHumansPregnancyProgesteroneProlactinThyrotropinPrimary Ovarian InsufficiencyChemotherapy, AdjuvantPremenopauseAntineoplastic Agents, HormonalAnti-Mullerian HormoneFertility PreservationOvarian Reserve

Keywords

MedicineOvarian reservePregnancyAnti-Müllerian hormoneHormoneProlactinFollicle-stimulating hormoneBreast cancerGynecologyInfertilityFertilityObstetricsCancerInternal medicinePopulationLuteinizing hormoneAssisted reproductive technologyPremature Ovarian InsufficiencyAnti-Mullerian HormonePREMENOPAUSALIMPACTOtros calificadores::Otros calificadores::Otros calificadores::/farmacoterapiaEmbaràsThyrotropinPrimary Ovarian InsufficiencyAMHRC254-282ProgesteroneOther subheadings::Other subheadings::Other subheadings::/drug therapyObstetrics & GynecologyWOMENNeoplasms. Tumors. Oncology. Including cancer and carcinogensFertility PreservationCHEMOTHERAPYTÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::técnicas reproductivas::técnicas reproductivas asistidasOncologyChemotherapy, AdjuvantOriginal ArticleFemaleLife Sciences & BiomedicineAdultAntineoplastic Agents, HormonalBreast NeoplasmsTÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::técnicas reproductivas::técnicas reproductivas asistidas::conservación de la fertilidad1117 Public Health and Health ServicesAGE3211 Oncology and carcinogenesisFENÓMENOS Y PROCESOS::fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::reproducción::embarazoHumansOncology & CarcinogenesisANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Reproductive Techniques::Reproductive Techniques, AssistedANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Reproductive Techniques::Reproductive Techniques, Assisted::Fertility PreservationScience & Technology3202 Clinical sciences1103 Clinical SciencesPHENOMENA AND PROCESSES::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproduction::PregnancyInternational Breast Cancer Study Group and the POSITIVE Trial CollaboratorsReproducció humana assistidaPremenopauseMama - Càncer - TractamentFollicle Stimulating HormoneENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mamaDISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms

Sustainable Development Goals

SDG 0: Good health and well-being

Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

FAIR Checklist

DataRank Breakdown

Authors (36)

Funding (16 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)